Gibson Dunn was named as the General Patent Litigation Firm of the Year at the annual LMG Life Sciences Awards. Two of the firm’s cases also were recognized: Novartis Pharmaceuticals v. Accord Healthcare was named the Hatch-Waxman Impact Case of the Year, and United States v. Arthrex was named in as the Patent Impact Case of the Year. (September 2021)